MedComm (Jun 2021)

Neoantigen‐reactive T cell: An emerging role in adoptive cellular immunotherapy

  • Yicheng Zhu,
  • Youkun Qian,
  • Zhile Li,
  • Yangyang Li,
  • Bin Li

DOI
https://doi.org/10.1002/mco2.41
Journal volume & issue
Vol. 2, no. 2
pp. 207 – 220

Abstract

Read online

Abstract Adoptive cellular immunotherapy harnessing the intrinsic immune system for precise treatment has exhibited preliminary success against malignant tumors. As one of the emerging roles in adoptive cellular immunotherapy, neoantigen‐reactive T cell (NRT) focuses on the antigens expressed only by tumor cells. It exclusively obliterates tumor and spares normal tissues, achieving more satisfying effects. However, the development of NRT immunotherapy remains in a relatively primitive stage. Current challenges include identification of NRTs and maintenance of adoptive cell efficacy in vivo. The possible side effects and other limitations of this treatment also hinder its application. Here, we present an overview of NRT immunotherapy and discuss the progress and challenges as well as the prospects in this promising field.

Keywords